Los puntos clave no están disponibles para este artículo en este momento.
Out of about 258,650 species of higher plants reported from the world; more than 10% are used to cure ailing communities. Beside many known drugs (e.g.tubocurarine, reserpine, aspirin and morphine etc) are discovered based on traditional knowledge. Majority of the people in Pakistan rely on medicinal plants to find treatment for their minor, even in some cases major diseases. Some wild plants are now being commonly used e.g. Ephedra, Artimisia, St. John’s wort,Hippophae beside some that have been domesticated e.g. Garlic, Ginseng and Cumin etc. There is a local market system (Pansara) specifically dealing with medicinal plants business in Pakistan and several plants are exported. Plants having active constituents are used to treat various ailments in both human and animal. In most instances, certain plant species are considered specific for a particular illness but occasionally they have mixed usage. Women, followed by children, are identified as the principal collectors of medicinal plants. Due to over-collection, several species have gone extinct in the Hindukush-Himalayan regions. Local collectors, vendors, herbal drug dealers and others are the ones who threaten the flora of Pakistan contribute (though unknowingly) to the extinction of some and bringing others to the brink of extinction. Though medicinal plants from wild are important source of income for local communities, but if not properly managed, this may lead to the destruction of habitat and in return extinction of species. There is therefore, a need to find ways to harvest medicinal plants sustainably from the wild, train local collectors (in proper collection techniques, train the people in growing medicinal plants, and remove some of the middlemen from the trading chain. In the present article, an effort was made to review the status of medicinal plants research in Pakistan. Key words: Medicinal plants of Pakistan, research and development, conservational issues, marketing, problems and prospects.
Zabta Khan Shinwari (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: